FY2026 EPS Estimates for Ekso Bionics Reduced by Analyst

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) – Investment analysts at HC Wainwright lowered their FY2026 earnings estimates for Ekso Bionics in a research note issued on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of $0.00 for the year, down from their prior estimate of $0.02. HC Wainwright has a “Buy” rating and a $9.00 price target on the stock. The consensus estimate for Ekso Bionics’ current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Ekso Bionics’ FY2027 earnings at $0.12 EPS and FY2029 earnings at $0.46 EPS.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, March 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.07). Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. The company had revenue of $5.09 million during the quarter, compared to analyst estimates of $5.05 million.

A number of other equities analysts also recently weighed in on the stock. StockNews.com initiated coverage on shares of Ekso Bionics in a report on Monday. They set a “hold” rating on the stock. Lake Street Capital decreased their price objective on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating for the company in a research report on Tuesday.

Ekso Bionics Stock Down 8.0 %

NASDAQ:EKSO opened at $0.44 on Wednesday. The firm has a market capitalization of $9.64 million, a price-to-earnings ratio of -0.67 and a beta of 1.46. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. Ekso Bionics has a twelve month low of $0.37 and a twelve month high of $1.64. The stock’s 50 day moving average price is $0.61 and its two-hundred day moving average price is $0.82.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.